Home › Politics › Lilly Buying Spree Surpasses $32B
Politics

Lilly Buying Spree Surpasses $32B

Key Points

Bloomberg Deals Nov 18th, 2026 Lilly Buying Spree Surpasses $32B Bloomberg’s Madison Muller joins Dani Burger on “Bloomberg Deals.” Eli Lilly agreed to buy closely held Calytrix Bio in a deal that could be worth up to $1.5 billion, the latest in the drugmaker’s $32 billion wave of acquisitions in 2026 as it builds out its cancer and immunology businesses.

Bloomberg Deals Nov 18th, 2026 Lilly Buying Spree Surpasses $32B Bloomberg’s Madison Muller joins Dani Burger on “Bloomberg Deals.” Eli Lilly agreed to buy closely held Calytrix Bio in a deal that could be worth up to $1.5 billion, the latest in the drugmaker’s $32 billion wave of acquisitions in 2026 as it builds out its cancer and immunology businesses.
Lilly Buying (ORG) Bloomberg (ORG) Madison Muller (PERSON) Dani Burger (PERSON) Eli Lilly (ORG) Calytrix Bio (ORG)
Originally published by Bloomberg Markets Read original →